You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Raloxifene

Showing 1 - 25 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postemenopusal Women With Osteopenia Trial in Seoul (Raloxifene plus cholecalciferol, Cholecalciferol)

Recruiting
  • Postemenopusal Women With Osteopenia
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
May 22, 2022

Rheumatoid Arthritis Trial (Raloxifene HCl, Placebo Oral Tablet)

Completed
  • Rheumatoid Arthritis
  • Raloxifene hydrochloride
  • Placebo Oral Tablet
  • (no location specified)
Dec 1, 2021

Osteopenia Trial (tibolone, raloxifen)

Completed
  • Osteopenia
  • (no location specified)
Feb 2, 2022

Xiao Chai Hu Tang, Irinotecan-induced Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Placebo, FOLFIRI/mXELIRI regimen)

Not yet recruiting
  • Xiao Chai Hu Tang
  • Irinotecan-induced Diarrhea
  • Xiao Chai Hu Tang (XCHT)
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Traditional Chinese Medicine
Sep 24, 2023

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Utrecht (Raloxifene, Placebo)

Completed
  • Schizophrenia
  • +3 more
  • Raloxifene
  • Placebo
  • Utrecht, Netherlands
    UMC Utrecht
Oct 4, 2021

SARS CoV 2 Infection Trial in France, Italy, Spain (Raloxifene, Placebo)

Completed
  • SARS CoV 2 Infection
  • Raloxifene
  • Placebo
  • Amiens, France
  • +10 more
Jan 10, 2022

Malignant Tumor, Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Raloxifene, FOLFIRI regimen)

Recruiting
  • Malignant Tumor
  • Diarrhea
  • Xiao Chai Hu Tang (XCHT)
  • +2 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Chinese Medicine
Aug 11, 2022

Combination Therapy With Raloxifene/Cholecalciferol

Completed
  • Osteoporosis
  • Observational
  • Seoul, Korea, Republic of
    Hanmi Pharmaceutical Company Limited
Mar 4, 2021

Rates of Esophageal Cancer in Women Taking Medications for

Completed
Has Results
  • Esophageal Cancer
  • +2 more
  • (no location specified)
Feb 1, 2022

Replication of HORIZON Pivotal Fracture Trial in Healthcare

Completed
  • Osteoporosis
  • Raloxifene
  • Zoledronic Acid
  • Boston, Massachusetts
    Brigham And Women's Hospital
Apr 30, 2021

Raloxifene, Postmenopausal Women Trial (coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S,

Completed
  • Raloxifene
  • Postmenopausal Women
  • coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S, antithrombin III and fibrinogen were studied.
  • (no location specified)
Jul 2, 2020

(PASS) in the European Union (EU)

Completed
Has Results
  • Osteoporosis, Postmenopausal
  • (no location specified)
Apr 27, 2020

Breast Cancer Trial in Rochester, Winnipeg (Polygenic Risk Score)

Completed
  • Breast Cancer
  • Polygenic Risk Score
  • Rochester, Minnesota
  • +1 more
Dec 28, 2020

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Melbourne (Raloxifene Hydrochloride, Placebo)

Unknown status
  • Schizophrenia
  • +2 more
  • Raloxifene Hydrochloride
  • Placebo
  • Melbourne, Victoria, Australia
    Alfred Hospital
Jan 6, 2020

Schizophrenia, Schizoaffective Disorder Trial in Melbourne (Raloxifene HCl, Placebo)

Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • Raloxifene hydrochloride
  • Placebo
  • Melbourne, Victoria, Australia
    Monash Alfred Psychiatry Research Centre
Jan 6, 2020

Schizophrenia Trial in Shanghai (Raloxifene Hydrochloride, Placebo)

Completed
  • Schizophrenia
  • Raloxifene Hydrochloride
  • Placebo
  • Shanghai, Minhang, China
    CHINA
Sep 4, 2019

Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial (Bicalutamide, Laboratory Biomarker Analysis,

Withdrawn
  • Stage I Prostate Adenocarcinoma
  • Stage II Prostate Adenocarcinoma
  • (no location specified)
Jan 17, 2019

Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)

Active, not recruiting
  • Metastatic Breast Cancer
  • Springfield, Massachusetts
  • +2 more
Nov 1, 2022

Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal

Active, not recruiting
  • Breast Cancer
  • Sample collection
  • Patient-reported outcomes
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 21, 2022

Osteoporosis Trial in Daegu (AD-101 45mg, Raloxifene 60mg)

Completed
  • Osteoporosis
  • AD-101 45mg
  • Raloxifene 60mg
  • Daegu, Korea, Republic of
    Kyungpook National University Hospital
Aug 29, 2019

Osteoporosis Trial in Seoul (Raloxifene 60mg/Cholecalciferol 800IU, AD-102)

Completed
  • Osteoporosis
  • Raloxifene 60mg/Cholecalciferol 800IU
  • AD-102
  • Seoul, Korea, Republic of
    Korea University Guro Hosptial
Aug 29, 2019

Factors Influencing Decision-Making About Use of Chemoprevention

Completed
  • Breast Cancer
  • Counseling session
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 4, 2021

Post-fracture Medication and Mortality

Completed
  • Osteoporosis
  • +4 more
  • Anti-osteoporosis medications
  • Tainan, Taiwan
    Department of Family Medicine, National Cheng Kung Univ Hosp
May 9, 2022

Vertebral Compression Fracture Trial in Worldwide (V-Flex, V-Steady)

Recruiting
  • Vertebral Compression Fracture
  • V-Flex
  • V-Steady
  • Calgary, Alberta, Canada
  • +6 more
Jan 6, 2023

Polycystic Ovarian Syndrome Trial in Greenville (Raloxifene, Clomiphene)

Terminated
Has Results
  • Polycystic Ovarian Syndrome
  • Greenville, South Carolina
    Greenville Hospital System
Aug 21, 2018